Skip to Main Content

The best and worst biopharma CEOs of 2020, selected by STAT+ readers, are Sam Kulkarni of CRISPR Therapeutics and Nick Leschly of Bluebird Bio.

This is one of the most fascinating paired selections in all the years that I’ve been naming best and worst biopharma CEOs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED